MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s13063-026-09579-6

Медицинская библиотека · Trials · 2026

The efficacy and safety of precision repetitive transcranial magnetic stimulation in alleviating motor symptoms in Parkinson's disease (PRESS-PD): a randomized, double-blind, multicenter, placebo-controlled trial.

Chen Xin, Ji Gong-Jun, Ye Rong, Sun Jinmei, Hu Lili, Han Jinying, Yu Liuzhenxiong, Li Yaqiang, Wu Junjun, Zhu Minhao, Cheng Jingjing, Liu Pingping, Liu Tingting, Sun Liyang, Yuan Junliang, Liang Zhanhua, Du Jing, Gong Liang, Zhang Kezhong, Sun Huiqin, Zhong Ping, Wang Kai, Hu Panpan

СтатьяРандомизированное исследованиеМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

As an innovative noninvasive neuromodulation technology, repetitive transcranial magnetic stimulation (rTMS) has demonstrated efficacy in improving motor symptoms in patients with Parkinson's disease (PD). The supplementary motor area (SMA) has been identified as a brain region significantly associated with motor symptoms in PD patients. However, no large-sample clinical studies have yet established the clinical efficacy of rTMS, guided by neuroimaging navigation, targeting the SMA in patients with PD.

METHODS

This study describes a randomized, double-blind, placebo-controlled, multicenter study designed to recruit 290 patients with primary PD. Participants will be randomly assigned to receive either real stimulation or sham stimulation, with the left SMA undergoing 7 days of continuous theta-burst stimulation (cTBS). The primary outcome measure is the changes in MDS-UPDRS III scores assessed from baseline to the end of 7-day treatment (on day 8). The secondary outcome is changes in other clinical symptom scores from baseline to day 8 and weeks 5 and 9. The study is expected to be conducted across eight medical centers in China, commencing in 2024 and concluding in 2026.

DISCUSSION: This study will evaluate the clinical efficacy and safety of cTBS targeting the left SMA in patients with PD. These findings may offer a new therapeutic approach for PD.

TRIAL REGISTRATION: ClinicalTrials.gov NCT06383247 (registered April 2024).

Для цитирования: Chen Xin, Ji Gong-Jun, Ye Rong, Sun Jinmei, Hu Lili, Han Jinying, Yu Liuzhenxiong, Li Yaqiang, Wu Junjun, Zhu Minhao, Cheng Jingjing, Liu Pingping, Liu Tingting, Sun Liyang, Yuan Junliang, Liang Zhanhua, Du Jing, Gong Liang, Zhang Kezhong, Sun Huiqin, Zhong Ping, Wang Kai, Hu Panpan. The efficacy and safety of precision repetitive transcranial magnetic stimulation in alleviating motor symptoms in Parkinson's disease (PRESS-PD): a randomized, double-blind, multicenter, placebo-controlled trial.. Trials. 2026. DOI: 10.1186/s13063-026-09579-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.